CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide... Show more
CBIZ, Inc. stands as a leading advisor to middle-market businesses, offering a comprehensive suite of services including accounting, tax, assurance, advisory, benefits, and insurance across more than 140 locations. Its competitive edge lies in scale-driven operating leverage, industry specialization in sectors like private equity, real estate, and technology, and a resilient business model with over 70% recurring revenue and client retention exceeding 90%. The company differentiates through multi-disciplinary expertise, enabling cross-serving and new client wins in a fragmented market where it captures meaningful share in the underserved middle-market segment (companies with $10 million to $1 billion in revenue).
Medium-term positioning is bolstered by ongoing integration of the Marcum acquisition, unlocking $50 million in cumulative synergies, and a disciplined M&A (mergers and acquisitions) approach focused on tuck-ins to enhance service breadth. Investments in talent and technology further support organic growth, positioning CBIZ to capitalize on regulatory tailwinds and client demand for integrated advisory solutions.
CBIZ's trajectory hinges on several near-term events. Quarterly earnings releases, with the next anticipated in late July or early August 2026, will provide updates on progress toward full-year guidance of adjusted diluted EPS (earnings per share) of $4.00-$4.10 and free cash flow of $270 million-$290 million. These reports are critical for validating revenue growth from industry vertical momentum and AI-driven efficiencies.
Synergy capture from the Marcum deal, projected at $12 million in 2026, could enhance margins and investor confidence. Analyst revisions remain a watchpoint; the current consensus of "Hold" from three to seven analysts, with price targets ranging from $31 to $60, may shift based on execution. Strategic M&A announcements and advancements in AI tools, such as data extraction and RFP generators, represent additional upside triggers by demonstrating productivity gains and new revenue streams.
The middle-market professional services industry, with a total addressable market exceeding 200,000 companies generating $10 trillion in annual revenue, enjoys secular tailwinds from increasing regulatory complexity and risk management needs. CBIZ's project-based revenue (28%) ties it to economic cycles, M&A momentum, and client spending on advisory.
Macro sensitivities include interest rates and inflation, which influence deal activity—elevated rates have led to a more selective environment but steady growth is forecasted for 2026. Geopolitical tensions and AI adoption trends offer both opportunities (e.g., tech advisory demand) and risks (e.g., cybersecurity), directly impacting CBIZ's benefits and insurance segments amid healthcare policy shifts.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying potential bullish, bearish, or sideways movements for stocks, ETFs, and other assets over the next week or month. It enables users to spot emerging trends, assess breakout or reversal possibilities, and review predictions across thousands of tradable instruments. Features include searchable prediction categories, historical performance context, and customizable alerts for timely insights. Explore the Trend Prediction Engine to enhance your trading strategy with data-driven foresight.
CBIZ anticipates 2%-5% revenue growth in 2026, with adjusted EBITDA margins supported by cost synergies and offshore expansion. Long-term themes include achieving 8%-10% annual revenue growth through AI transformation, global capabilities scaling to improve utilization by over 20%, and capital allocation prioritizing debt reduction (target net leverage below 2.5x by 2027), M&A, and share repurchases ($63 million YTD).
Market expansion in high-growth verticals like technology and life sciences, alongside margin sustainability from operating leverage, will be pivotal. Competitive threats from Big Four firms and regulatory changes in tax/assurance pose risks, but CBIZ's middle-market focus and 72% recurring revenue provide resilience. Consensus analyst expectations, with a $41.33 average price target, underscore measured optimism tied to execution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a provider of financial and employee benefits services
Industry OfficeEquipmentSupplies
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CAPE | 32.97 | 0.41 | +1.25% |
| DoubleLine Shiller CAPE US Equities ETF | |||
| TMFX | 23.32 | 0.17 | +0.74% |
| Motley Fool Next ETF | |||
| HEFT | 26.22 | 0.01 | +0.04% |
| Hedgeye Fourth Turning ETF | |||
| FJUN | 59.85 | -0.03 | -0.06% |
| FT Vest US Equity Buffer ETF Jun | |||
| TSXU | 56.76 | -4.06 | -6.68% |
| Direxion Daily Smndctrs Top 5 Bull 2XETF | |||
A.I.dvisor indicates that over the last year, CBZ has been loosely correlated with EXPO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CBZ jumps, then EXPO could also see price increases.
| Ticker / NAME | Correlation To CBZ | 1D Price Change % |
|---|---|---|
| CBZ | 100% | +2.48% |
| Office Equipment/Supplies industry (46 stocks) | -1% Poorly correlated | +0.25% |
| Producer Manufacturing industry (352 stocks) | -12% Poorly correlated | -0.69% |
The RSI Indicator for CBZ moved out of oversold territory on June 23, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In of the 19 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on July 01, 2026. You may want to consider a long position or call options on CBZ as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CBZ just turned positive on July 01, 2026. Looking at past instances where CBZ's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
CBZ moved above its 50-day moving average on June 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBZ advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .
CBZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 280 cases where CBZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for CBZ crossed bearishly below the 50-day moving average on June 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 22 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CBZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.812) is normal, around the industry mean (15.299). P/E Ratio (11.239) is within average values for comparable stocks, (69.346). CBZ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.465). CBZ has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.023). P/S Ratio (0.648) is also within normal values, averaging (8.491).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.